Kyoto University Finds Stem Cell Researcher Guilty of Data Fabrication

The scientist was a member of a stem cell research team led by Nobel laureate Shinya Yamanaka.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, JPELLGENUpdate (March 30): Kyoto University has fired Kohei Yamamizu, Retraction Watch reports. Shinya Yamanaka also received an as-yet-unknown penalty.

Kyoto University announced the results of an investigation into research misconduct this week (January 22), finding one of its scientists—who was part of a research group headed by Nobel laureate Shinya Yamanaka—guilty of falsifying data in a study published in Stem Cell Reports last year. The university has requested that the journal retract the paper, Reuters reports.

The investigation concluded that the lead author of the paper, Kohei Yamamizu, had fabricated all six main figures of the study, which were “pivotal in the conclusions the author drew,” Yamanaka told a press conference (via Nikkei Asian Review). The authors had claimed success in modelling the blood-brain barrier in vitro using induced pluripotent stem (iPS) cells.

Yamamizu is an assistant professor in a research group led by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies